The comparison of the effect of roasted lentil flour and tranexamic acid on the amount of menstrual bleeding and quality of life in women suffering from heavy menstrual bleeding

Evaluation of the effect of roasted lentil flour in heavy menstrual bleeding and quality of life in comparison with tranexamic acid in women suffering from menorrhagia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017072935363N1

Enrollment

Registered

2017-09-19

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menorrhagia. Excessive and frequent menstruation with regular cycle

Interventions

Intervention 1: Intervention group is treated with roasted lentil flour in the form of 10 gram sachets, fasting morning 3 sachets from the beginning of the menstrual bleeding to 7 days. Intervention 2

Treatment - Drugs

Intervention group is treated with roasted lentil flour in the form of 10 gram sachets, fasting morning 3 sachets from the beginning of the menstrual bleeding to 7 days.

Control group is given two 250 mg tranexamic acid capsule every 8 hours from the beginning of the menstrual bleeding to 7 days.

Eligibility

Sex/Gender

Female

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Regular menstrual cycle ; Having a score more than 100 in Pictorial blood assessment chart ; Age between 18 to 55 years old ; No abnormal pap smear or ultrasonography ; No systemic disease (Thyroid, Hyperprolactinemia, Coagulopathy, Diabetes) ; No organic diseases such as uterine or ovary disease or other malignancies ; No consumption of drugs that effect on amount of menstrual bleeding (OCP, ASA) since 2 months ; No pregnancy. Exclusion criteria: Unwilling to continue participation in the study ; Incidence of side-effects requiring special treatment ; The use of any hormonal or contraceptive drug during the study ; Pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Amount of bleeding. Timepoint: One month before, first, second and third month after intervention. Method of measurement: Higam Chart.;Duration of bleeding. Timepoint: One month before, first, second and third month after intervention. Method of measurement: Higam Chart.	—

Secondary

Measure	Time frame
Quality of life. Timepoint: Before and 3 months after intervention. Method of measurement: Menorrhagia questionnaire.;Hb level. Timepoint: Before and 3 months after intervention. Method of measurement: Lab test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Malihe Shafiei

Qom University of Medical Sciences

mshafiei@muq.ac.ir+98 25 3770 7843

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026